Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
72.0%
% of BBH's 27 holdings also in FBT
60.0%
% of FBT's 31 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 4.0% | 4.3% | 4.0% |
 |
ARGENX SE ADR | 5.6% | 3.8% | 3.8% |
|
GILEAD SCIENCES INC | 10.9% | 3.6% | 3.6% |
|
ILLUMINA INC | 4.4% | 3.3% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 10.8% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to FBT
|
AMGEN INC | 12.5% |
|
VERTEX PHARMACEUTICALS INC | 7.5% |
|
GILEAD SCIENCES INC | 7.3% |
|
IQVIA HOLDINGS INC | 4.6% |
|
REGENERON PHARMACEUTICALS | 4.1% |
 |
ICON PLC | 3.5% |
|
BIO-TECHNE CORPORATION | 2.2% |
|
INSMED INC | 2.2% |
|
QIAGEN NV | 2.0% |
|
CHARLES RIVER LABORATORIES | 1.8% |
BBH Underweight Relative to FBT
|
EXELIXIS INC | -4.5% |
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ACADIA PHARMACEUTICALS INC | -3.9% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
CATALYST PHARMACEUTICAL PART | -3.6% |
|
WATERS CORP | -3.6% |
|
ALKERMES PLC | -3.6% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
HALOZYME THERAPEUTICS INC | -3.0% |
|
BRUKER CORP | -3.0% |